|
Report Date : |
17.09.2014 |
IDENTIFICATION DETAILS
|
Name : |
MISSIONPHARMA A S |
|
|
|
|
Registered Office : |
Vassingeradvej
9, Lynge 3540 |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
2013 |
|
|
|
|
Date of Incorporation : |
16.12.2002 |
|
|
|
|
Com. Reg. No.: |
26902398 |
|
|
|
|
Legal Form : |
Limited Company |
|
|
|
|
Line of Business : |
Wholesale
of Pharmaceutical and Nursing Goods. |
|
|
|
|
No of Employees : |
45 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 01, 2014
|
Country Name |
Previous Rating (31.03.2014) |
Current Rating (01.06.2014) |
|
|
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderate Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderate High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
DENMARK - ECONOMIC
OVERVIEW
This thoroughly modern market economy features a high-tech agricultural sector, state-of-the-art industry with world-leading firms in pharmaceuticals, maritime shipping and renewable energy, and a high dependence on foreign trade. Denmark is a member of the European Union (EU); Danish legislation and regulations conform to EU standards on almost all issues. Danes enjoy a high standard of living and the Danish economy is characterized by extensive government welfare measures and an equitable distribution of income. Denmark is a net exporter of food and energy and enjoys a comfortable balance of payments surplus, but depends on imports of raw materials for the manufacturing sector. Within the EU, Denmark is among the strongest supporters of trade liberalization. After a long consumption-driven upswing, Denmark's economy began slowing in 2007 with the end of a housing boom. Housing prices dropped markedly in 2008-09 and, following a short respite in 2010, have since continued to decline. Household indebtedness is still relatively high at more than 275% of gross disposable income in the first half of 2013. The global financial crisis has exacerbated this cyclical slowdown through increased borrowing costs and lower export demand, consumer confidence, and investment. Denmark made a modest recovery in 2010, in part because of increased government spending; however, the country experienced a technical recession in late 2010-early 2011. Historically low levels of unemployment rose sharply with the recession and have remained at about 6% in 2010-13, based on the national measure, about two-thirds average EU unemployment. An impending decline in the ratio of workers to retirees will be a major long-term issue. Denmark maintained a healthy budget surplus for many years up to 2008, but the budget balance swung into deficit in 2009, where it remains. In spite of the deficits, the new coalition government delivered a modest stimulus to the economy in 2012. Nonetheless, Denmark's fiscal position remains among the strongest in the EU with public debt at about 46% of GDP in 2013. Despite previously meeting the criteria to join the European Economic and Monetary Union (EMU), so far Denmark has decided not to join, although the Danish krone remains pegged to the euro.
|
Source
: CIA |
|
Business Name |
Missionpharma
A/S |
|
Country |
DENMARK |
|
Company
Registration Number/CVR |
26902398 |
|
Main Code |
464610 |
|
Main Activity |
Wholesale
of pharmaceutical and nursing goods |
|
Company Status |
Active |
|
Latest Revenue |
|
|
Latest Shareholder
Equity |
124.385 |
|
Description |
Businesses at this level are regarded as having excellent
creditworthiness. Small businesses only have a limited possibility of
achieving this level. Businesses at this level are in a class by themselves
and will have results or financial foundations which are among the best in
the country. The credit risk is regarded as minimal. |
|
Basic Information |
|
|
Business Name |
Missionpharma
A/S |
|
Registered
Company Name |
Missionpharma
A/S |
|
Company
Registration Number |
26902398 |
|
Country |
DENMARK |
|
Date of Company
Registration |
2002-12-06 |
|
Legal Form |
Limited
company |
|
Company Status |
Active |
|
Currency of this
Report |
DKK |
|
Principal
Activity Code |
464610 |
|
Principal Activity
Description |
Wholesale
of pharmaceutical and nursing goods |
|
Contact Address |
Vassingeradvej
9, Lynge 3540 |
|
Contact Telephone
Number |
48163200 |
|
|
Activity Description |
|
464610 |
Wholesale
of pharmaceutical and nursing goods |
|
464620 |
Wholesale
of medical and hospital goods |
|
Profit and Loss |
|||
|
Financial Date |
2013 |
2012 |
2012 |
|
Number of Weeks |
52 |
35 |
52 |
|
Currency |
DKK |
DKK |
DKK |
|
Revenue |
537.927.000 |
387.645.000 |
619.055.000 |
|
Operating
Profit |
69.046.000 |
48.453.000 |
36.595.000 |
|
Retained Profit |
44.083.000 |
35.246.000 |
26.429.000 |
|
|
|||
|
Balance Sheet |
|||
|
Financial Date |
2013 |
2012 |
2012 |
|
Number of Weeks |
52 |
35 |
52 |
|
Currency |
DKK |
DKK |
DKK |
|
Main Address |
||
|
Address |
Country |
Telephone |
|
Vassingeradvej
9, Lynge 3540 |
DENMARK |
48163200 |
Email
Addresses
Web
Pages
|
Currency |
DKK |
|
Nominal Share
Capital |
1.000.000 |
|
Current Directors |
||
|
|
Position |
Start
Date |
|
Kim Erik
Ginnerup |
Managing
director |
|
|
Poul
Lindof |
General
manager |
|
|
Jean-Marc
Pierre Rene Leccia |
Chairman |
|
|
Denis
Georges Fernand Maurice |
Deputy
Chairman |
|
|
Eric
Pierre Jean Muris |
Member
of the board |
|
|
Kim Erik
Ginnerup |
Member of
the board |
|
|
Erik
Stavnstrup |
Finance |
|
|
Ultimate Holding
Parent |
|
|
Name |
Country |
|
P.
Ginnerup ApS |
|
|
Subsidiaries |
|
|
Name |
Country |
|
PharmaDanica
A/S |
DENMARK |
|
Missionpharma
Logistics Pvt Ltd |
INDIA |
|
Employee
Information |
|
|
Year
Reported |
Number
of Employees |
|
2013 |
45 |
|
2012 |
51 |
|
2012 |
50 |
|
Real Estate |
|
|
Real
Estate |
No |
|
Other Trading
Names |
|
|
Type |
Name |
|
Business
name |
International
Project Services A/S |
|
Business
name |
Missionpharma
International A/S |
|
Business
name |
Missionpharma
International Project Services A/S |
|
Business
name |
Missionpharma
International Relief Services A/S |
Global
Trading Information
Export Europe
Import
|
Other Information |
|
|
Type |
Text |
|
Historical
data |
In 2003 the company took over the activities previously
carried on by Missionpharma Interna.Proj.Services A/S (16929484. |
|
Capital
conditions |
fully
paid up |
|
Additional
Accounts Information |
|
|
Date Format |
MM-DD |
|
Accounts Start
Date |
01-01 |
|
Accounts End Date |
12-31 |
|
Other Trading
Names |
|
|
Type |
Name |
|
Business
name |
International
Project Services A/S |
|
Business
name |
Missionpharma
International A/S |
|
Business
name |
Missionpharma
International Project Services A/S |
|
Business
name |
Missionpharma
International Relief Services A/S |
|
|
|
|
Global Trading
Information |
|
|
Export
Import |
Europe |
|
|
|
|
Other Information |
|
|
Type |
Text |
|
Historical
data |
In 2003 the company took over the
activities previously carried on by Missionpharma Interna.Proj.Services
A/S(16929484. |
|
Capital
conditions |
fully
paid up |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.61.10 |
|
UK Pound |
1 |
Rs.99.05 |
|
Euro |
1 |
Rs.79.03 |
INFORMATION DETAILS
|
Analysis Done by
: |
SUB |
|
|
|
|
Report Prepared
by : |
NIT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.